Diabetes & obesity

ENG

ICE 2024

Innovation in diabetes technology use

Asma Deeb, MD

ENG

ICE 2024

Type 2 Diabetes medication for Type 1 Diabetes…

Antje Körner, MD

ENG

ICE 2024

The year in obesity

Antje Körner, MD

ENG

ICE 2024

There is a big deal about prediabetes!

Antje Körner, MD

ENG

ICE 2024

Precision medicine; monogenic obesity as a model

Asma Deeb, MD

ENG

ICE 2024

Changing landscape in childhood obesity

Hala Tfayli, MD

ENG

ICE 2024

Controversies on AI application for patient clustering

Antje Körner, MD

ENG

ICE 2024

Gaps & opportunities for precision medicine in diabetes

Antje Körner, MD

ENG

ICE 2024

Insights from monogenic obesity

Antje Körner, MD

ENG

ICE 2024

Metabolic liver disease

Antje Körner, MD

ENG

ICE 2024

Gestational diabetes: What is new?

Antje Körner, MD

ENG

ICE 2024

Precision medicine; neonatal diabetes as a model

Asma Deeb, MD

Diabetes & obesity – multilanguage

GER

ICE 2024

Metabolische Lebererkrankungen

Antje Körner, MD

GER

ICE 2024

Möglichkeiten der Präzisionsmedizin bei Diabetes

Antje Körner, MD

GER

ICE 2024

Schwangerschaftsdiabetes: Was gibt es Neues?

Antje Körner, MD

GER

ICE 2024

There is a big deal about prediabetes!

Antje Körner, MD

GER

ICE 2024

Einsichten von der monogenen Adipositas

Antje Körner, MD

GER

ICE 2024

Typ-2-Diabetes-Medikation für Patienten mit…

Antje Körner, MD

GER

ICE 2024

Kontroversen der KI-Anwendung für Patientenclustering

Antje Körner, MD

GER

ICE 2024

Das Jahr in Obesity

Antje Körner, MD

Adrenal

ENG

ICE 2024

Advances in treatment of CAH

Asma Deeb, MD

ENG

ICE 2024

Hypertension - how you see it, how don't

Richard Quinton, MD

ENG

ICE 2024

Mineralocorticoid associated hypertension - obstacles &…

Richard Quinton, MD

ENG

ICE 2024

Which alpha blockade before operation of…

Heide Siggelkow, MD

ENG

ICE 2024

New diagnostic tools for adrenal insufficiency

Asma Deeb, MD

ENG

ICE 2024

Use of mitotane in China

Heide Siggelkow, MD

ENG

ICE 2024

Diastolic dysfunction - core management and bolt-ons

Richard Quinton, MD

Adrenal – multilanguage

GER

ICE 12024

Welche alpha-Blockade vor Operation beim…

Heide Siggelkow, MD

GER

ICE 2024

Mitotane in der täglichen Therapie in China

Heide Siggelkow, MD

Neuroendocrinology & pituitary

ENG

ICE 2024

New PCOS guidelines - aspects in adolescents

Antje Körner, MD

ENG

ICE 2024

International PCOS guidelines - diagnostic aspects

Nils Krone, MD

ENG

ICE 2024

Inpatient hypernatremia overshot isn´t somebodies fault…

Richard Quinton, MD

ENG

ICE 2024

Is the monthly dosis of octreotid in acomegaly…

Heide Siggelkow, MD

ENG

ICE 2024

Aspects of adolescent PCOS

Nils Krone, MD

ENG

ICE 2024

Routine preoperative steroid treatment for pituitary…

Richard Quinton, MD

ENG

ICE 2024

How to predict resistence in acromegaly therapy?

Heide Siggelkow, MD

ENG

ICE 2024

The first oral treatment of acromegaly

Heide Siggelkow, MD

ENG

ICE 2024

Better ways of understanding long-term complications of…

Nils Krone, MD

ENG

ICE 2024

Highlights in pituitary

Nils Krone, MD

ENG

ICE 2024

Sucess of surgery for acromegaly comparing in contrast…

Richard Quinton, MD

ENG

ICE 2024

MRA scanning in pituitary microadenomas - less is more

Richard Quinton, MD

ENG

ICE 2024

Updates on PCOS diagnosis in adolescents

Hala Tfayli, MD

ENG

ICE 2024

International guidelines of PCOS - key lessons for…

Richard Quinton, MD

Neuroendocrinology & pituitary – multilanguage

GER

ICE 2024

Neue PCOS Guidelines - Aspekte bezüglich Jugendlichen

Antje Körner, MD

GER

ICE 2024

Kann die Therapieresistenz bei Akromegalie vorhergesagt…

Heide Siggelkow, MD

GER

ICE 2024

Die erste Tablette zur Therapie der Akromegalie

Heide Siggelkow, MD

GER

ICE 2024

Ist monatliche Oktreotid-Gabe bei Akromegalie effektiv?

Heide Siggelkow, MD

Thyroid

ENG

ICE 2024

Mental health in pediatric endocrinology

Nils Krone, MD

ENG

ICE 2024

Thyroid hormone resistance and transport defects-focus…

Nils Krone, MD

ENG

ICE 2024

What's new in thyroid cancer?

Antje Körner, MD

ENG

ICE 2024

Thyroid cancer

Nils Krone, MD

ENG

ICE 2024

Immunotherapy-related Endocrinopathies

Nils Krone, MD

Thyroid – multilanguage

GER

ICE 2024

Neues bei den Schilddrüsentumoren

Antje Körner, MD

Calcium & bone

ENG

ICE 2024

Is there an optimal therapy for osteoporosis and type 2…

Heide Siggelkow, MD

ENG

ICE 2024

Novel therapies in metabolic bone disease;…

Asma Deeb, MD

ENG

ICE 2024

Another PTH molecule for anabolic osteoporosis therapy

Heide Siggelkow, MD

ENG

ICE 2024

Genetic reasons for hypercalcemia

Heide Siggelkow, MD

ENG

ICE 2024

FSH blocking medication - good for everything?

Heide Siggelkow, MD

ENG

ICE 2024

Novel therapies in metabolic bone disease; XLH

Asma Deeb, MD

Calcium & bone – multilanguage

GER

ICE 2024

Ein weiteres PTH-Molekül für die anabole…

Heide Siggelkow, MD

GER

ICE 2024

Genetische Gründe für eine Hyperkalzämie

Heide Siggelkow, MD

GER

ICE 2024

Gibt es eine optimale Therapie bei Osteoporose und…

Heide Siggelkow, MD

GER

ICE 2024

FSH-blockierende Medikamente - ein Allrounder?

Heide Siggelkow, MD

DSD

ENG

ICE 2024

Turner syndrome - optimizing uterine volumes is also…

Richard Quinton, MD

ENG

ICE 2024

XY-female; a medical & social dilemma

Asma Deeb, MD

ENG

ICE 2024

Puberty induction in Turner syndrome

Antje Körner, MD

ENG

ICE 2024

Hyperaldosteronism - should we screen all patients on…

Nils Krone, MD

DSD multilanguage

GER

ICE 2024

Pubertätsinduktion beim Turner-Syndrom

Antje Körner, MD

Reproduction & development

ENG

ICE 2024

Induction of spermatogenesis

Nils Krone, MD

ENG

ICE 2024

So you thought you already knew the course?

Richard Quinton, MD

Cross-cutting highlights

ENG

ICE 2024

Disparity in health care

Hala Tfayli, MD

ENG

ICE 2024

Mental health in paediatric endocrinology

Nils Krone, MD

ENG

ICE 2024

On the way to precision medicine in paediatric…

Hala Tfayli, MD